Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 3/2020

01.03.2020 | Review Article

Apical variant hypertrophic cardiomyopathy “multimodality imaging evaluation”

verfasst von: Gary Huang, Shaimaa A. Fadl, Stan Sukhotski, Manuela Matesan

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Apical variant hypertrophic cardiomyopathy (AHCM) is characterized by asymmetric hypertrophy of the left ventricular (LV) apex. T wave inversions of variable degree, particularly in the left precordial leads, and left ventricular hypertrophy (LVH) are common EKG findings in AHCM. Echocardiography is typically the initial imaging modality used in the diagnosis and evaluation of AHCM. The diagnosis is made when the LV apex has apical wall thickness of ≥ 15 mm or a ratio of apical to basal LV wall thickness of ≥ 1.3 at end-diastole. The use of microbubble contrast agents with echocardiography is helpful for visualization of the apex. Cardiac magnetic resonance (CMR) has the advantage of a large field of view and the ability to perform tissue characterization. Late gadolinium enhancement (LGE) sequences are essential in the assessment of potential areas of myocardial scarring. Cardiac computed tomography (CCT) has the advantage of being able to evaluate coronary arteries in addition to assessing cardiac anatomy and function. A “Solar Polar” map pattern is the characteristic feature of AHCM on myocardial perfusion imaging (MPI) in cases not associated with apical aneurysm (APA). Recognition of typical perfusion patterns in AHCM patients is not only important in the diagnostic evaluation of this disease process, but also for avoiding unnecessary and costly tests. The purpose of this article is to review the imaging features of AHCM from different imaging modalities and assess the value added of each modality in the diagnosis of AHCM.
Literatur
1.
Zurück zum Zitat Eriksson MJ et al (2002) Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 39(4):638–645PubMedCrossRef Eriksson MJ et al (2002) Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 39(4):638–645PubMedCrossRef
2.
Zurück zum Zitat Ho HH et al (2004) Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy. Am J Med 116(1):19–23PubMedCrossRef Ho HH et al (2004) Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy. Am J Med 116(1):19–23PubMedCrossRef
3.
Zurück zum Zitat Kitaoka H et al (2003) Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 92(10):1183–1186PubMedCrossRef Kitaoka H et al (2003) Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 92(10):1183–1186PubMedCrossRef
4.
Zurück zum Zitat Moon JC et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90(6):645–649PubMedPubMedCentralCrossRef Moon JC et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90(6):645–649PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Jan MF et al (2016) Apical hypertrophic cardiomyopathy: present status. Int J Cardiol 222:745–759PubMedCrossRef Jan MF et al (2016) Apical hypertrophic cardiomyopathy: present status. Int J Cardiol 222:745–759PubMedCrossRef
6.
Zurück zum Zitat Cerqueira MD et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4):539–542PubMedCrossRef Cerqueira MD et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4):539–542PubMedCrossRef
7.
Zurück zum Zitat Kim EK et al (2016) Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur Heart J Cardiovasc Imaging 17(6):678–686PubMedCrossRef Kim EK et al (2016) Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur Heart J Cardiovasc Imaging 17(6):678–686PubMedCrossRef
8.
Zurück zum Zitat Gersh BJ et al (2011) ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011. 58(25):e212–e260PubMedCrossRef Gersh BJ et al (2011) ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011. 58(25):e212–e260PubMedCrossRef
9.
Zurück zum Zitat Choi EY et al (2008) Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: multicenter echo-Doppler study. Cardiology 110(1):53–61PubMedCrossRef Choi EY et al (2008) Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: multicenter echo-Doppler study. Cardiology 110(1):53–61PubMedCrossRef
10.
Zurück zum Zitat Di Tullio MR et al (1999) Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke 30(10):2019–2024PubMedCrossRef Di Tullio MR et al (1999) Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke 30(10):2019–2024PubMedCrossRef
11.
Zurück zum Zitat Takemoto Y et al (2005) Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol 96(6):832–836PubMedCrossRef Takemoto Y et al (2005) Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol 96(6):832–836PubMedCrossRef
12.
Zurück zum Zitat Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39.e14PubMedCrossRef Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39.e14PubMedCrossRef
13.
Zurück zum Zitat Yang H et al (2005) Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr 18(10):1074–1082PubMedCrossRef Yang H et al (2005) Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr 18(10):1074–1082PubMedCrossRef
14.
Zurück zum Zitat Spirito P et al (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342(24):1778–1785PubMedCrossRef Spirito P et al (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342(24):1778–1785PubMedCrossRef
15.
Zurück zum Zitat Biswas M et al (2013) Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions. Echocardiography 30(1):88–105PubMedCrossRef Biswas M et al (2013) Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions. Echocardiography 30(1):88–105PubMedCrossRef
16.
Zurück zum Zitat Chang SA et al (2010) Left ventricular twist mechanics in patients with apical hypertrophic cardiomyopathy: assessment with 2D speckle tracking echocardiography. Heart 96(1):49–55PubMedCrossRef Chang SA et al (2010) Left ventricular twist mechanics in patients with apical hypertrophic cardiomyopathy: assessment with 2D speckle tracking echocardiography. Heart 96(1):49–55PubMedCrossRef
17.
Zurück zum Zitat Saccheri MC et al (2017) Speckle tracking echocardiography to assess regional ventricular function in patients with apical hypertrophic cardiomyopathy. World J Cardiol 9(4):363–370PubMedPubMedCentralCrossRef Saccheri MC et al (2017) Speckle tracking echocardiography to assess regional ventricular function in patients with apical hypertrophic cardiomyopathy. World J Cardiol 9(4):363–370PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Binder J et al (2011) Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr 24(7):775–781PubMedCrossRef Binder J et al (2011) Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr 24(7):775–781PubMedCrossRef
19.
Zurück zum Zitat Rowin EJ et al (2017) Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management. J Am Coll Cardiol 69(7):761–773PubMedCrossRef Rowin EJ et al (2017) Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management. J Am Coll Cardiol 69(7):761–773PubMedCrossRef
20.
Zurück zum Zitat Matsubara K et al (2003) Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42(2):288–295PubMedCrossRef Matsubara K et al (2003) Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42(2):288–295PubMedCrossRef
21.
Zurück zum Zitat Kim H et al (2016) Significance of apical cavity obliteration in apical hypertrophic cardiomyopathy. Heart 102(15):1215–1220PubMedCrossRef Kim H et al (2016) Significance of apical cavity obliteration in apical hypertrophic cardiomyopathy. Heart 102(15):1215–1220PubMedCrossRef
22.
Zurück zum Zitat Minami Y, Haruki S, Hagiwara N (2014) Phenotypic overlap in hypertrophic cardiomyopathy: apical hypertrophy, midventricular obstruction, and apical aneurysm. J Cardiol 64(6):463–469PubMedCrossRef Minami Y, Haruki S, Hagiwara N (2014) Phenotypic overlap in hypertrophic cardiomyopathy: apical hypertrophy, midventricular obstruction, and apical aneurysm. J Cardiol 64(6):463–469PubMedCrossRef
23.
Zurück zum Zitat Maron MS et al (2008) Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118(15):1541–1549PubMedCrossRef Maron MS et al (2008) Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118(15):1541–1549PubMedCrossRef
24.
Zurück zum Zitat Nagueh SF et al (2011) American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 24(5):473–498PubMedCrossRef Nagueh SF et al (2011) American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 24(5):473–498PubMedCrossRef
25.
26.
Zurück zum Zitat Geske JB et al (2007) Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation 116(23):2702–2708PubMedCrossRef Geske JB et al (2007) Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation 116(23):2702–2708PubMedCrossRef
27.
Zurück zum Zitat Nishimura RA et al (1996) Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 28(5):1226–1233PubMedCrossRef Nishimura RA et al (1996) Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 28(5):1226–1233PubMedCrossRef
28.
Zurück zum Zitat Kitaoka H et al (2013) Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 14(6):544–549PubMedCrossRef Kitaoka H et al (2013) Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 14(6):544–549PubMedCrossRef
29.
Zurück zum Zitat Kitaoka H et al (2011) Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 24(9):1020–1025PubMedCrossRef Kitaoka H et al (2011) Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 24(9):1020–1025PubMedCrossRef
30.
Zurück zum Zitat Nagueh SF et al (1999) Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 99(2):254–261PubMedCrossRef Nagueh SF et al (1999) Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 99(2):254–261PubMedCrossRef
31.
Zurück zum Zitat Nagueh SF et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314PubMedCrossRef Nagueh SF et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314PubMedCrossRef
32.
Zurück zum Zitat Nakamura T et al (1992) Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 19(3):516–524PubMedCrossRef Nakamura T et al (1992) Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 19(3):516–524PubMedCrossRef
33.
Zurück zum Zitat Mulvagh SL et al (2008) American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr 21(11):1179–201 (quiz 1281)PubMedCrossRef Mulvagh SL et al (2008) American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr 21(11):1179–201 (quiz 1281)PubMedCrossRef
34.
Zurück zum Zitat Minami Y et al (2011) Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 57(23):2346–2355PubMedCrossRef Minami Y et al (2011) Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 57(23):2346–2355PubMedCrossRef
36.
Zurück zum Zitat Amano Y et al (2018) Cardiac MR imaging of hypertrophic cardiomyopathy: techniques, findings, and clinical relevance. Magn Reson Med Sci 17(2):120–131PubMedPubMedCentralCrossRef Amano Y et al (2018) Cardiac MR imaging of hypertrophic cardiomyopathy: techniques, findings, and clinical relevance. Magn Reson Med Sci 17(2):120–131PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Baxi AJ et al (2016) Hypertrophic cardiomyopathy from A to Z: genetics, pathophysiology, imaging, and management. Radiographics 36(2):335–354PubMedCrossRef Baxi AJ et al (2016) Hypertrophic cardiomyopathy from A to Z: genetics, pathophysiology, imaging, and management. Radiographics 36(2):335–354PubMedCrossRef
39.
Zurück zum Zitat Yamada M et al (2009) Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study. Int J Cardiovasc Imaging 25(Suppl 1):131–138PubMedCrossRef Yamada M et al (2009) Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study. Int J Cardiovasc Imaging 25(Suppl 1):131–138PubMedCrossRef
40.
Zurück zum Zitat Olivotto I et al (2012) Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail 5(4):535–546PubMedCrossRef Olivotto I et al (2012) Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail 5(4):535–546PubMedCrossRef
41.
Zurück zum Zitat Morishita S et al (2001) Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy. Am J Cardiol 87(6):743–747PubMedCrossRef Morishita S et al (2001) Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy. Am J Cardiol 87(6):743–747PubMedCrossRef
42.
Zurück zum Zitat Ward RP et al (2003) Resting "Solar Polar" map pattern and reduced apical flow reserve: characteristics of apical hypertrophic cardiomyopathy on SPECT myocardial perfusion imaging. J Nucl Cardiol 10(5):506–512PubMedCrossRef Ward RP et al (2003) Resting "Solar Polar" map pattern and reduced apical flow reserve: characteristics of apical hypertrophic cardiomyopathy on SPECT myocardial perfusion imaging. J Nucl Cardiol 10(5):506–512PubMedCrossRef
43.
Zurück zum Zitat Cianciulli TF et al (2009) Myocardial perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy. J Nucl Cardiol 16(3):391–395PubMedCrossRef Cianciulli TF et al (2009) Myocardial perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy. J Nucl Cardiol 16(3):391–395PubMedCrossRef
44.
Zurück zum Zitat Zhou Y et al (2019) Development and validation of a new method to diagnose apical hypertrophic cardiomyopathy by gated single-photon emission computed tomography myocardial perfusion imaging. Nucl Med Commun 40(3):206–211PubMedCrossRef Zhou Y et al (2019) Development and validation of a new method to diagnose apical hypertrophic cardiomyopathy by gated single-photon emission computed tomography myocardial perfusion imaging. Nucl Med Commun 40(3):206–211PubMedCrossRef
45.
Zurück zum Zitat Yamamoto H et al (2017) Occasionally increased (18)F-fluorodeoxyglucose uptake in apical hypertrophic cardiomyopathy with mid-ventricular obstruction. J Cardiol Cases 16(2):44–47PubMedPubMedCentralCrossRef Yamamoto H et al (2017) Occasionally increased (18)F-fluorodeoxyglucose uptake in apical hypertrophic cardiomyopathy with mid-ventricular obstruction. J Cardiol Cases 16(2):44–47PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Takeishi Y et al (2017) Cardiac imaging with (18)F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy. J Nucl Cardiol 24(5):1827–1828PubMedCrossRef Takeishi Y et al (2017) Cardiac imaging with (18)F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy. J Nucl Cardiol 24(5):1827–1828PubMedCrossRef
48.
Zurück zum Zitat Akbulut A et al (2019) The detection of apical variant of hypertrophic cardiomyopathy in myocardial perfusion imaging. Acta Cardiol 74:1–3 Akbulut A et al (2019) The detection of apical variant of hypertrophic cardiomyopathy in myocardial perfusion imaging. Acta Cardiol 74:1–3
49.
Zurück zum Zitat Zein RK et al (2017) An uncommon variant of an uncommon disease: a Caucasian adolescent with apical hypertrophic cardiomyopathy diagnosed with myocardial perfusion imaging. World J Nucl Med 16(3):251–254PubMedPubMedCentralCrossRef Zein RK et al (2017) An uncommon variant of an uncommon disease: a Caucasian adolescent with apical hypertrophic cardiomyopathy diagnosed with myocardial perfusion imaging. World J Nucl Med 16(3):251–254PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Masrur S et al (2016) SPECT myocardial perfusion imaging in the diagnosis of apical hypertrophic cardiomyopathy. Tex Heart Inst J 43(5):467–468PubMedPubMedCentralCrossRef Masrur S et al (2016) SPECT myocardial perfusion imaging in the diagnosis of apical hypertrophic cardiomyopathy. Tex Heart Inst J 43(5):467–468PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Jouni H, Geske JB, Miller TD (2013) The diagnosis of apical hypertrophic cardiomyopathy with myocardial perfusion imaging. Heart 99(14):1064–1065PubMedCrossRef Jouni H, Geske JB, Miller TD (2013) The diagnosis of apical hypertrophic cardiomyopathy with myocardial perfusion imaging. Heart 99(14):1064–1065PubMedCrossRef
52.
Zurück zum Zitat Hsieh BP, Travin MI (2012) Myocardial perfusion image findings in apical hypertrophic cardiomyopathy. J Nucl Cardiol 19(1):172–176PubMedCrossRef Hsieh BP, Travin MI (2012) Myocardial perfusion image findings in apical hypertrophic cardiomyopathy. J Nucl Cardiol 19(1):172–176PubMedCrossRef
53.
Zurück zum Zitat Russo RR et al (2010) Severe ischaemia on SPECT myocardial perfusion imaging secondary to microvascular dysfunction and apical hypertrophic cardiomyopathy. Clin Nucl Med 35(12):937–940PubMedCrossRef Russo RR et al (2010) Severe ischaemia on SPECT myocardial perfusion imaging secondary to microvascular dysfunction and apical hypertrophic cardiomyopathy. Clin Nucl Med 35(12):937–940PubMedCrossRef
54.
Zurück zum Zitat Irwin RB, Arumugam P, Khattar RS (2010) Incidental detection of apical hypertrophic cardiomyopathy by myocardial perfusion imaging. Nucl Med Commun 31(4):286–293PubMedCrossRef Irwin RB, Arumugam P, Khattar RS (2010) Incidental detection of apical hypertrophic cardiomyopathy by myocardial perfusion imaging. Nucl Med Commun 31(4):286–293PubMedCrossRef
55.
Zurück zum Zitat Minamimoto R et al (2013) Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening. Ann Nucl Med 27(6):572–580PubMedCrossRef Minamimoto R et al (2013) Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening. Ann Nucl Med 27(6):572–580PubMedCrossRef
Metadaten
Titel
Apical variant hypertrophic cardiomyopathy “multimodality imaging evaluation”
verfasst von
Gary Huang
Shaimaa A. Fadl
Stan Sukhotski
Manuela Matesan
Publikationsdatum
01.03.2020
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 3/2020
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-019-01739-x

Weitere Artikel der Ausgabe 3/2020

The International Journal of Cardiovascular Imaging 3/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.